Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print March 27, 2008, 10.1148/radiol.2472070798

(Radiology 2008;247:451.)

A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow All Versions of this Article:
2472070798v1
247/2/451    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Takahashi, N.
Right arrow Articles by King, B. F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, N.
Right arrow Articles by King, B. F.
© RSNA, 2008

Genitourinary Imaging

Small (<2-cm) Upper-Tract Urothelial Carcinoma: Evaluation with Gadolinium-enhanced Three-dimensional Spoiled Gradient-Recalled Echo MR Urography1

Naoki Takahashi, MD, Akira Kawashima, MD, PhD, James F. Glockner, MD, PhD, Robert P. Hartman, MD, Bradley C. Leibovich, MD, Anja C. S. Brau, PhD, Philip J. Beatty, PhD, and Bernard F. King, MD

1 From the Departments of Radiology (N.T., A.K., J.F.G., R.P.H., B.F.K.) and Urology (B.C.L.), Mayo Clinic, 200 First St SW, Rochester, MN 55905; and GE Healthcare, Global Applied Science Lab, Menlo Park, Calif (A.C.S.B., P.J.B.). Received May 7, 2007; revision requested July 10; revision received August 1; accepted August 16; final version accepted September 28. Address correspondence to N.T.

Purpose: To retrospectively evaluate the detection of small (<2-cm) urothelial tumors by using gadolinium-enhanced three-dimensional (3D) spoiled gradient-recalled echo (GRE) magnetic resonance (MR) urography.

Materials and Methods: This HIPAA-compliant study received institutional review board approval. All patients included had previously consented to the use of their medical records for research purposes. Eleven of 110 patients (10 men, one woman; mean age, 73.5 years) who underwent MR urography were ultimately identified to have 23 upper-tract urothelial carcinomas smaller than 2 cm or carcinoma in situ. Breath-hold coronal T2-weighted single-shot fast spin-echo and breath-hold coronal 3D T1-weighted spoiled GRE images with fat suppression during nephrographic and excretory phases after intravenous injection of gadolinium-based contrast material were obtained in all patients with a 1.5-T imager. Two radiologists reviewed the MR images in consensus for the presence of tumors. Lesion detectability was compared between each sequence by using the McNemar test.

Results: Of 23 tumors, 17 (74%) were detected by using at least one sequence, eight (35%) were detected with T2-weighted imaging, 15 (65%) were detected on nephrographic phase images, and 15 (65%) were detected on excretory phase images. Two lesions each were detected only on either nephrographic or excretory phase images. Detectability was significantly higher on nephrographic and excretory phase images compared with T2-weighted images (P < .05).

Conclusion: Gadolinium-enhanced 3D spoiled GRE MR urography helped detect 74% of small urothelial carcinomas. Nephrographic and excretory phase images are essential for helping detect small urothelial carcinomas.

© RSNA, 2008







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2008 by the Radiological Society of North America.